Bausch Health to Announce Second Quarter 2025 Results on July 30
-
Third-ever confirmed interstellar object blazing through Solar System
-
Joao Pedro arrival boosts Chelsea ahead of Palmeiras Club World Cup test
-
Lions start to roar in ominous Wallabies warning
-
Kellaway, Tupou headline Waratahs team to face Lions
-
Four All Blacks debutants to face France in first Test
-
Ukraine scrambling for clarity as US downplays halt to arms shipments
-
Peru clinic that leaked Shakira medical record given hefty fine
-
UK's Starmer backs finance minister after tears in parliament
-
Trump tax bill stalled by Republican rebellion in Congress
-
US stocks back at records as oil prices rally
-
Norway battle back to beat Swiss hosts in Euro 2025 opener
-
Netanyahu vows to uproot Hamas as ceasefire proposals are discussed
-
Tarvet won't turn pro yet, despite pushing Alcaraz at Wimbledon
-
Ukraine left scrambling after US says halting some arms shipments
-
India captain Gill's hundred repels England in second Test
-
Possible interstellar object spotted zooming through Solar System
-
Alcaraz ends Tarvet's Wimbledon adventure, Paolini crashes out
-
Why is there no life on Mars? Rover finds a clue
-
Former finalist Paolini stunned as Wimbledon seeds continue to fall
-
Tesla reports lower car sales, extending slump
-
Finland open Women's Euro 2025 with win over Iceland
-
India captain Gill hits another hundred against England in 2nd Test
-
Hamas mulls truce proposals after Trump Gaza ceasefire push
-
Alcaraz ends Tarvet's Wimbledon adventure, Sabalenka advances
-
Tears, prayers, exultation: Diddy radiates relief after partial acquittal
-
Ruthless Alcaraz ends Tarvet's Wimbledon fairytale
-
Bangladesh collapse in ODI series opener to hand Sri Lanka big win
-
Trump says Vietnam to face 20% tariff under 'great' deal
-
US senator urges bribery probe over Trump-Paramount settlement
-
Nazi-sympathising singer's huge gig to paralyse Zagreb
-
Germany swelters as European heatwave moves eastwards
-
Sabalenka tells troubled Zverev to talk to family about mental health issues
-
Hong Kong govt proposes limited recognition of same-sex couples' rights
-
Wall Street shrugs off drop US private sector jobs
-
Spain star Bonmati recovering well from meningitis, says coach Tome
-
Pogacar must 'battle' for Tour de France title says director
-
Tesla reports lower car sales but figures better than feared
-
Alcaraz aims to avoid Wimbledon giant-killing after Sabalenka wins
-
England captain Stokes makes Jaiswal breakthrough in second Test
-
Sean 'Diddy' Combs acquitted of sex trafficking, convicted on lesser charge
-
Sabalenka praying for no more Wimbledon upsets after battling win
-
Hamas says discussing proposals after Trump Gaza ceasefire push
-
Teen plotting attacks on women charged in France's first 'incel' case
-
Sabalenka overcomes Bouzkova challenge to reach Wimbledon third round
-
Stocks stuck as US private sector jobs disappoint, UK's Reeves future uncertain
-
Asalanka ton leads Sri Lanka to 244 in first Bangladesh ODI
-
UK govt backs finance minister after tears in parliament
-
US private sector shed jobs for first time in recent years: ADP
-
Chelsea sign Brazil striker Joao Pedro from Brighton
-
Farrell says slow-starting Lions still have work to do
Bausch Health to Announce Second Quarter 2025 Results on July 30
LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, July 30, 2025 |
Time: | 5:00 p.m. U.S. EDT |
Webcast: |
A replay of the conference call will be available on the investor relations website.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll-free) | (908) 541-3785 |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
P.Mathewson--AMWN
